Feature | January 27, 2015

3-D Printed Tissue Offers Viable Option for Tracheal Reconstruction

Printed material can be combined with patient’s own cells for customized tissue segments

3-D printing, tracheal reconstruction, STS, Goldstein, Feinstein Institute

Daniel A. Grande, Ph.D., director of the orthopedic research laboratory at the Feinstein Institute, and Todd Goldstein, an investigator at the Feinstein Institute, part of the North Shore-LIJ Health System, with their MakerBot Replicator desktop 3-D printer that they used to 3-D print cartilage to repair tracheal damage.

January 27, 2015 — Three-dimensional (3-D) printing can effectively create a biodegradable tracheal segment containing a patient’s own cells for use in complex tracheal reconstruction, according to a proof of concept study abstract released at the 51st Annual Meeting of The Society of Thoracic Surgeons.

Traditional treatments for tracheal diseases such as stenosis or malacia (abnormal softening of the tissue) usually involve removal of the affected tracheal segment.

“Three-dimensional printing and tissue engineering has the potential for creation of a custom-designed tracheal replacement prosthesis in the lab so that the affected tracheal segment can be ‘swapped out’ instead of removed,” said lead author Todd Goldstein, Ph.D., of the Feinstein Institute for Medical Research, part of the North Shore-LIJ Health System in New York. “Making a windpipe or trachea is uncharted territory. It has to be rigid enough to withstand coughs, sneezes and other shifts in pressure, yet flexible enough to allow the neck to move freely. With 3-D printing, we were able to construct 3-D printed scaffolding that the surgeons could immediately examine and then we could work together in real time to modify the designs.”

Goldstein and colleagues used a custom-designed MakerBot Replicator 2X Experimental 3-D printer that had been modified by engineers to enable printing of living cells. The printer produces a biodegradable scaffold that can be combined with living cells to create a tracheal segment. The size and shape of the scaffold can be customized for each patient. This is a first for medical research where regular MakerBot PLA Filament was used to 3-D print a custom tracheal scaffolding, which was combined with living cells to create a tracheal segment.

“MakerBot was extremely helpful and consulted on optimizing our design files so they would print better and provided advice on how to modify the MakerBot Replicator 2X Experimental 3-D Printer to print with PLA and the biomaterial,” said Goldstein. “We actually found designs to modify the printer on MakerBot’s Thingiverse website to print PLA with one extruder and the biomaterial with the other extruder. We 3-D-printed the needed parts with our other MakerBot Replicator Desktop 3-D Printer, and used them to modify the MakerBot Replicator 2X Experimental 3-D Printer so that we could better iterate and test our ideas.”

For their study, the researchers made three types of printed segments: empty segments, segments without cells (controls) and segments that had been combined with living cells. The bio-printed cells were tested for viability, proliferation (cell growth and division) and gene expression. The researchers found that the cells survived the printing process, were able to continue dividing and produced the cellular properties expected in healthy tracheal cartilage.

“Our results show that three-dimensional printing can be combined with tissue engineering to effectively produce a partial tracheal replacement graft in vitro,” said Goldstein. “Our data demonstrate that the cartilage cells seeded on the graft retain their biological capability and were able to proliferate at the same rate as native cells.”

The authors said that 3-D printing has the potential to revolutionize medicine; patients are already seeing benefits from the technology in the area of customized prosthetics for limb replacement. Reconstructive craniofacial and cardiothoracic surgeons also have been using 3-D printers to build models for more precise surgical planning. 

“We think the next phase will be integrating three-dimensional printing and tissue engineering to produce customized biological replacement parts,” said Goldstein. “While further development is necessary before a clinical trial would be viable, our results show that 3-D printing technology is a feasible alternative to traditional treatments.”

3-D printed tissue is not yet approved by the U.S. Food and Drug Administration.

For more information: www.sts.org

Related Content

Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite
Technology | Advanced Visualization | June 13, 2019
Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food and Drug...
Technological Advancements Expected to Drive Virtual Reality Growth in Healthcare
News | Advanced Visualization | April 04, 2019
Increasing demand for innovative diagnostic techniques, neurological disorders and increasing disease awareness are...
DrChrono and 3D4Medical Partner to Bring 3-D Interactive Modeling to Physician Practices
News | Advanced Visualization | March 18, 2019
DrChrono Inc. and 3D4Medical have teamed up so practices across the United States can access 3-D interactive modeling...
Videos | Advanced Visualization | March 05, 2019
Augmented reality (AR) and virtual reality (VR) are starting to be adopted for physician training, patient education
Philips Introduces IntelliSpace Portal 11 at ECR 2019
Technology | Advanced Visualization | February 27, 2019
Philips announced the launch of IntelliSpace Portal 11, the latest release of the company’s comprehensive, advanced...
Philips and Microsoft have partnered to develop an augmented reality system to help imporve workflow and procedural navigation in the cath lab. Physicians wearing visors can view and interact with true 3-D holograms above the patient on the table and manipulate the image with voice and hand motion commands to avoid breaking the sterile field. Virtual reality in the cath lab, interventional lab, hybrid OR, or cardiovascular lab.

Philips and Microsoft have partnered to develop an augmented reality system to help imporve workflow and procedural navigation in the cath lab. Physicians wearing visors can view and interact with true 3-D holograms above the patient on the table and manipulate the image with voice and hand motion commands to avoid breaking the sterile field. 

News | Advanced Visualization | February 25, 2019
Philips will unveil a new mixed reality concept developed together with Microsoft that the company says is designed for...
Medivis Launches SurgicalAR Augmented Reality Platform
Technology | Advanced Visualization | February 14, 2019
Medical imaging and visualization company Medivis officially unveiled SurgicalAR, its augmented reality (AR) technology...
Videos | Advanced Visualization | December 12, 2018
This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at t
Nihon Kohden Launches Augmented Reality Electrophysiology Training App at HIMSS18
Technology | Advanced Visualization | March 06, 2018
Nihon Kohden announced the launch of the Nihon Kohden Dimensions Augmented Reality (AR) App to complement the Clinical...
NIH Issues $2.2 Million Grant for Augmented Reality Cardiac Hologram Research
News | Advanced Visualization | February 15, 2018
February 15, 2018 — The National Institutes of Health (NIH) awarded a $2.2 million research grant to healthcare techn
Overlay Init